Call for paper: Front Oncol (IF4.137) and Front Genet (IF3.517)

https://www.frontiersin.org/research-topics/10686/the-role-of-ncrnas-in-solid-tumors-prognosis-from-laboratory-to-clinical-utility

Research Topic

The Role of ncRNAs in Solid Tumors Prognosis: From Laboratory To Clinical Utility

About this Research Topic

Noncoding RNAs (ncRNAs) are involved in the regulation of various cell processes, including transcription, intracellular trafficking, and chromosome remodeling. Their dysregulation has been associated with the development and progression of various types of cancers, which makes them promising cancer biomarkers. In recent years, the detection of cancer-associated ncRNAs in body fluids of cancer patients has proven itself as a particularly valuable method to effectively diagnose cancer. Cancer prognosis employing circulating ncRNAs is preferential when compared to traditional tumor tissue biopsies, especially due to their noninvasiveness, and have great potential for routine application in clinical practice. Thus, this article collection focuses on summarizing the perspectives of ncRNAs as biomarkers in cancer, based on evaluating their expression profiles determined in body fluids of cancer patients.

The stability of ncRNAs in body fluids of cancer patients has not been thoroughly explored. Although several studies have demonstrated that ncRNAs, unlike lncRNAs, are highly stable under diverse temperature and storage conditions, our understanding of the former is still at the initial stages, especially for the more recently detected ncRNAs such as microRNA, lncRNAs, piRNAs, and circRNAs.

In this Research Topic, we would like to present the recent advances on the roles of ncRNAs on tumorigenesis, metastasis, chemoresistance, radioresistance as well as their potential clinical applications in solid cancers. We welcome the submission of Original Research, Review and Systematic Review articles dedicated to:

1) The mechanisms of ncRNAs in cancer development and progression

2) Large scale analysis of ncRNAs

3) Identification and validation the ncRNA prognostic model for cancers by TCGA, GEO or original data

Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Submission Deadlines

04 August 2019 Abstract

02 December 2019 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Frontiers in Oncology

Frontiers in Genetics

Call For Paper

Call for paper(IF5.2):A Promising Therapeutic Target in Cancer

2019-9-3 19:00:08

Call For Paper

Call for paper:Journal of Zhejiang University-SCIENCE B生物医学与生物技术类综合SCI期刊

2019-9-3 19:00:37

声明 本网站部分文章源于互联网,出于传递更多信息和学习之目的转载,并不保证内容正确或赞同其观点。
如转载稿涉及失效、版权等问题,请立即联系管理员;我们会予以修改、删除相关文章,请留言反馈
Notice: When your legal rights are being violated, please send an email to: [email protected]
0 条回复 A文章作者 M管理员
    暂无讨论,说说你的看法吧
个人中心
购物车
优惠劵
今日签到
有新私信 私信列表
搜索